Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending August 3, 2004. The document primarily reports on corporate actions regarding share buybacks and changes in directors' interests in company shares held through various employee benefit trusts and retirement plans.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The only financial data presented relates to specific share transaction prices and volumes:
- Share Buyback (July 28): 900,000 shares purchased at 1,103.6668 pence per share.
- Share Buyback (July 30): 900,000 shares purchased at 1,109.2216 pence per share.
- Treasury Shares (Post-July 30): 28,218,000 shares held in Treasury.
- Shares in Issue (Post-July 30): 5,905,742,984 shares (excluding Treasury).
- US Retirement Plan ADRs: Fluctuated between approximately 18.97 million and 19.03 million ADRs at average prices of $40.60 and $40.67.
Material Changes
The primary material changes reported are:
- Capital Reduction: The company executed two share repurchases totaling 1.8 million shares in late July 2004, increasing its Treasury holdings from 27,318,000 to 28,218,000 shares.
- Directors' Interests: Various employee trusts (SmithKline Beecham Employee Benefit Trust, GSK Trust, and US Retirement Savings Plan) transferred shares to participants or experienced fund movements. These changes affect the indirect share interests of directors John Coombe, Dr. J-P Garnier, and Dr. T Yamada.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It is a regulatory disclosure of specific transactions and director shareholdings.
Key Facts for Investor Verification
- Verify the total cost of the 1.8 million share buyback executed in late July 2004.
- Confirm the updated total number of shares in issue (5,905,742,984) and Treasury shares (28,218,000) as of July 30, 2004.
- Note that directors' reported interests are indirect, derived from their status as potential beneficiaries of discretionary employee trusts rather than direct ownership changes.
- Observe that the filing explicitly states it does not constitute an offer to purchase or subscribe for securities.